{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T01:00:37Z","timestamp":1780275637692,"version":"3.54.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":42,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100005047","name":"Natural Science Foundation of Liaoning Province","doi-asserted-by":"publisher","award":["2024-BS-319"],"award-info":[{"award-number":["2024-BS-319"]}],"id":[{"id":"10.13039\/501100005047","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"DOI":"10.1186\/s13256-026-06055-2","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T02:45:56Z","timestamp":1776653156000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immunotherapy-based neoadjuvant treatment of gastric cancer with elevated serum AFP: a case report"],"prefix":"10.1186","volume":"20","author":[{"given":"Yuanlin","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyu","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junqiao","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanmei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deyu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingdong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,20]]},"reference":[{"key":"6055_CR1","first-page":"1277","volume":"78","author":"J Bourreille","year":"1970","unstructured":"Bourreille J. Existence of alpha-fetoprotein during gastric-origin secondary cancer of the liver. Presse m\u00e9d. 1970;78:1277\u20138.","journal-title":"Presse m\u00e9d"},{"issue":"6","key":"6055_CR2","first-page":"6345","volume":"8","author":"D Wang","year":"2015","unstructured":"Wang D, Li C, Xu Y, et al. Clinicopathological characteristics and prognosis of alpha-fetoprotein positive gastric cancer in Chinese patients. Int J Clin Exp Pathol. 2015;8(6):6345\u201355.","journal-title":"Int J Clin Exp Pathol"},{"issue":"1","key":"6055_CR3","doi-asserted-by":"publisher","first-page":"23","DOI":"10.5230\/jgc.2011.11.1.23","volume":"11","author":"H Chun","year":"2011","unstructured":"Chun H, Kwon SJ. Clinicopathological characteristics of alpha-fetoprotein-producing gastric cancer. J Gastric Cancer. 2011;11(1):23\u201330.","journal-title":"J Gastric Cancer"},{"issue":"10","key":"6055_CR4","first-page":"1470","volume":"124","author":"JF Zhang","year":"2011","unstructured":"Zhang JF, Shi SS, Shao YF, et al. Clinicopathological and prognostic features of hepatoid adenocarcinoma of the stomach. Chin Med J (Engl). 2011;124(10):1470\u20136.","journal-title":"Chin Med J (Engl)"},{"key":"6055_CR5","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/1471-230X-11-56","volume":"11","author":"SK Baek","year":"2011","unstructured":"Baek SK, Han SW, Oh DY, et al. Clinicopathologic characteristics and treatment outcomes of hepatoid adenocarcinoma of the stomach, a rare but unique subtype of gastric cancer. BMC Gastroenterol. 2011;11:56.","journal-title":"BMC Gastroenterol"},{"issue":"7","key":"6055_CR6","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1002\/bjs.7081","volume":"97","author":"M Inoue","year":"2010","unstructured":"Inoue M, Sano T, Kuchiba A, et al. Long-term results of gastrectomy for alpha-fetoprotein-producing gastric cancer. Br J Surg. 2010;97(7):1056\u201361.","journal-title":"Br J Surg"},{"issue":"2","key":"6055_CR7","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1159\/000072332","volume":"65","author":"Y Adachi","year":"2003","unstructured":"Adachi Y, Tsuchihashi J, Shiraishi N, et al. AFP-producing gastric carcinoma: multivariate analysis of prognostic factors in 270 patients. Oncology. 2003;65(2):95\u2013101.","journal-title":"Oncology"},{"issue":"3","key":"6055_CR8","doi-asserted-by":"publisher","first-page":"e394","DOI":"10.3747\/co.21.1768","volume":"21","author":"HJ Lin","year":"2014","unstructured":"Lin HJ, Hsieh YH, Fang WL, et al. Clinical manifestations in patients with alpha-fetoprotein-producing gastric cancer. Curr Oncol. 2014;21(3):e394\u20139.","journal-title":"Curr Oncol"},{"issue":"2","key":"6055_CR9","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1159\/000012152","volume":"59","author":"H Amemiya","year":"2000","unstructured":"Amemiya H, Kono K, Mori Y, et al. High frequency of c-Met expression in gastric cancers producing alpha- fetoprotein. Oncology. 2000;59(2):145\u201351.","journal-title":"Oncology"},{"issue":"6","key":"6055_CR10","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1007\/s00535-002-1099-y","volume":"38","author":"S Kamei","year":"2003","unstructured":"Kamei S, Kono K, Amemiya H, et al. Evaluation of VEGF and VEGF-C expression in gastric cancer cells producing alpha-fetoprotein. J Gastroenterol. 2003;38(6):540\u20137.","journal-title":"J Gastroenterol"},{"issue":"6","key":"6055_CR11","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1007\/s11596-018-1983-1","volume":"38","author":"XY Zeng","year":"2018","unstructured":"Zeng XY, Yin YP, Xiao H, et al. Clinicopathological characteristics and prognosis of hepatoid adenocarcinoma of the stomach: evaluation of a pooled case series. Curr Med Sci. 2018;38(6):1054\u201361.","journal-title":"Curr Med Sci"},{"issue":"10","key":"6055_CR12","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1001\/jamaoncol.2020.3370","volume":"6","author":"K Shitara","year":"2020","unstructured":"Shitara K, van Cutsem E, Bang YJ, et al. Efficacy and safety of pembrolizumab or pembrolizumab plus chemotherapy vs chemotherapy alone for patients with first-line, advanced gastric cancer: the keynote-062 phase 3 randomized clinical trial. JAMA Oncol. 2020;6(10):1571\u201380.","journal-title":"JAMA Oncol"},{"issue":"3","key":"6055_CR13","doi-asserted-by":"publisher","first-page":"560","DOI":"10.21037\/jgo.2018.03.01","volume":"9","author":"J Chuang","year":"2018","unstructured":"Chuang J, Gong J, Klempner SJ, et al. Refining the management of resectable esophagogastric cancer: FLOT4, CRITICS, OE05, MAGIC-B and the promise of molecular classification. J Gastrointest Oncol. 2018;9(3):560\u201372.","journal-title":"J Gastrointest Oncol"},{"issue":"1","key":"6055_CR14","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa055531","volume":"355","author":"D Cunningham","year":"2006","unstructured":"Cunningham D, Allum WH, Stenning SP, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355(1):11\u201320.","journal-title":"N Engl J Med"},{"issue":"9813","key":"6055_CR15","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0140-6736(11)61873-4","volume":"379","author":"YJ Bang","year":"2012","unstructured":"Bang YJ, Kim YW, Yang HK, et al. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial. Lancet. 2012;379(9813):315\u201321.","journal-title":"Lancet"},{"issue":"7","key":"6055_CR16","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1093\/annonc\/mdu146","volume":"25","author":"E Bajetta","year":"2014","unstructured":"Bajetta E, Floriani I, di Bartolomeo M, et al. Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer. Ann Oncol. 2014;25(7):1373\u20138.","journal-title":"Ann Oncol"},{"issue":"3","key":"6055_CR17","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1200\/JCO.2011.39.1953","volume":"30","author":"J Lee","year":"2012","unstructured":"Lee J, Lim DH, Kim S, et al. Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial. J Clin Oncol. 2012;30(3):268\u201373.","journal-title":"J Clin Oncol"},{"issue":"10","key":"6055_CR18","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.1016\/j.ejso.2020.06.034","volume":"46","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Cheng S, Gong J, Lu M, Zhou J, Zhang X, Li J, Shen L, Peng Z. Efficacy and safety of neoadjuvant immunotherapy in patients with microsatellite instability-high gastrointestinal malignancies: a case series. Eur J Surg Oncol. 2020;46(10):e33\u20139.","journal-title":"Eur J Surg Oncol"},{"issue":"8","key":"6055_CR19","doi-asserted-by":"publisher","first-page":"857","DOI":"10.6004\/jnccn.2022.7023","volume":"20","author":"L Liu","year":"2022","unstructured":"Liu L, Woo Y, D\u2019Apuzzo M, et al. Immunotherapy-based neoadjuvant treatment of advanced microsatellite instability-high gastric cancer: a case series. J Natl Compr Canc Netw. 2022;20(8):857\u201365.","journal-title":"J Natl Compr Canc Netw"},{"issue":"2","key":"6055_CR20","doi-asserted-by":"publisher","first-page":"174","DOI":"10.3109\/00365515609049266","volume":"8","author":"CG Bergstrand","year":"1956","unstructured":"Bergstrand CG, Czar B. Demonstration of a new protein fraction in serum from the human fetus. Scand J Clin Lab Invest. 1956;8(2):174.","journal-title":"Scand J Clin Lab Invest"},{"key":"6055_CR21","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.rmed.2016.09.003","volume":"119","author":"K Grossman","year":"2016","unstructured":"Grossman K, Beasley MB, Braman SS. Hepatoid adenocarcinoma of the lung: review of a rare form of lung cancer. Respir Med. 2016;119:175\u20139.","journal-title":"Respir Med"},{"issue":"3","key":"6055_CR22","doi-asserted-by":"publisher","first-page":"321","DOI":"10.3748\/wjg.v19.i3.321","volume":"19","author":"JS Su","year":"2013","unstructured":"Su JS, Chen YT, Wang RC, et al. Clinicopathological characteristics in the differential diagnosis of hepatoid adenocarcinoma: a literature review. World J Gastroenterol. 2013;19(3):321\u20137.","journal-title":"World J Gastroenterol"},{"key":"6055_CR23","doi-asserted-by":"publisher","first-page":"11113","DOI":"10.2147\/CMAR.S276969","volume":"12","author":"W Li","year":"2020","unstructured":"Li W, Li Q, Yu Y, et al. Effect of immune checkpoint inhibitors plus chemotherapy on advanced gastric cancer patients with elevated serum AFP or Hepatoid adenocarcinoma. Cancer Manag Res. 2020;12:11113\u20139.","journal-title":"Cancer Manag Res"},{"key":"6055_CR24","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1186\/1477-7819-11-246","volume":"11","author":"XD Li","year":"2013","unstructured":"Li XD, Wu CP, Ji M, et al. Characteristic analysis of alpha-fetoprotein-producing gastric carcinoma in China. World J Surg Oncol. 2013;11:246.","journal-title":"World J Surg Oncol"},{"issue":"36","key":"6055_CR25","doi-asserted-by":"publisher","first-page":"6055","DOI":"10.3748\/wjg.v19.i36.6055","volume":"19","author":"S Hirajima","year":"2013","unstructured":"Hirajima S, Komatsu S, Ichikawa D, et al. Liver metastasis is the only independent prognostic factor in AFP-producing gastric cancer. World J Gastroenterol. 2013;19(36):6055\u201361.","journal-title":"World J Gastroenterol"},{"key":"6055_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.901061","volume":"12","author":"Z Zhan","year":"2022","unstructured":"Zhan Z, Chen B, Yu J, et al. Elevated serum alpha-fetoprotein is a significant prognostic factor for patients with gastric cancer: results based on a large-scale retrospective study. Front Oncol. 2022;12: 901061.","journal-title":"Front Oncol"},{"issue":"1","key":"6055_CR27","doi-asserted-by":"publisher","first-page":"3695","DOI":"10.1038\/s41598-024-54394-1","volume":"14","author":"Y Takayama-Isagawa","year":"2024","unstructured":"Takayama-Isagawa Y, Kanetaka K, Kobayashi S, et al. High serum alpha-fetoprotein and positive immunohistochemistry of alpha-fetoprotein are related to poor prognosis of gastric cancer with liver metastasis. Sci Rep. 2024;14(1):3695.","journal-title":"Sci Rep"},{"issue":"8","key":"6055_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-024-03743-0","volume":"73","author":"T Deng","year":"2024","unstructured":"Deng T, Wang F, Zhang L, et al. Combinational zimberelimab plus lenvatinib and chemotherapy for alpha-fetoprotein elevated, advanced gastric cancer patients (AFPGC): a phase 1 dose-escalation study. Cancer Immunol Immunother. 2024;73(8): 154.","journal-title":"Cancer Immunol Immunother"},{"issue":"2","key":"6055_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2020.101004","volume":"14","author":"N Li","year":"2021","unstructured":"Li N, Bai C, Zhang R, et al. Efficacy and safety of apatinib for the treatment of AFP-producing gastric cancer. Transl Oncol. 2021;14(2): 101004.","journal-title":"Transl Oncol"},{"issue":"3","key":"6055_CR30","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.3892\/ol.2017.6514","volume":"14","author":"Y Arakawa","year":"2017","unstructured":"Arakawa Y, Tamura M, Aiba K, et al. Significant response to ramucirumab monotherapy in chemotherapy-resistant recurrent alpha-fetoprotein-producing gastric cancer: a case report. Oncol Lett. 2017;14(3):3039\u201342.","journal-title":"Oncol Lett"},{"issue":"3","key":"6055_CR31","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.21037\/jgo-22-462","volume":"13","author":"W Weng","year":"2022","unstructured":"Weng W, Zhang M, Ni S, et al. Decreased expression of claudin-18.2 in alpha-fetoprotein-producing gastric cancer compared to conventional gastric cancer. J Gastrointest Oncol. 2022;13(3):1035\u201345.","journal-title":"J Gastrointest Oncol"},{"key":"6055_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.962126","volume":"12","author":"L Wang","year":"2022","unstructured":"Wang L, Feng Y, Huang A, et al. Case report: significant response to PD-L1 inhibitor after resistance to PD-1 inhibitor in an advanced alpha-fetoprotein-positive gastric cancer. Front Oncol. 2022;12: 962126.","journal-title":"Front Oncol"},{"issue":"3","key":"6055_CR33","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1136\/jclinpath-2017-204535","volume":"71","author":"K Arora","year":"2018","unstructured":"Arora K, Bal M, Shih A, et al. Fetal-type gastrointestinal adenocarcinoma: a morphologically distinct entity with unfavourable prognosis. J Clin Pathol. 2018;71(3):221\u20137.","journal-title":"J Clin Pathol"},{"issue":"12","key":"6055_CR34","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1136\/jcp.56.12.942","volume":"56","author":"H Fujii","year":"2003","unstructured":"Fujii H, Ichikawa K, Takagaki T, et al. Genetic evolution of alpha fetoprotein producing gastric cancer. J Clin Pathol. 2003;56(12):942\u20139.","journal-title":"J Clin Pathol"},{"issue":"4","key":"6055_CR35","first-page":"553","volume":"6","author":"C Ponzetto","year":"1991","unstructured":"Ponzetto C, Giordano S, Peverali F, et al. c-met is amplified but not mutated in a cell line with an activated met tyrosine kinase. Oncogene. 1991;6(4):553\u20139.","journal-title":"Oncogene"},{"issue":"1","key":"6055_CR36","doi-asserted-by":"publisher","first-page":"3946","DOI":"10.1038\/s41467-021-24170-0","volume":"12","author":"J Lu","year":"2021","unstructured":"Lu J, Ding Y, Chen Y, et al. Whole-exome sequencing of alpha-fetoprotein producing gastric carcinoma reveals genomic profile and therapeutic targets. Nat Commun. 2021;12(1):3946.","journal-title":"Nat Commun"},{"issue":"10","key":"6055_CR37","doi-asserted-by":"publisher","first-page":"12018","DOI":"10.1002\/cam4.5883","volume":"12","author":"Y Mei","year":"2023","unstructured":"Mei Y, Li M, Wen J, et al. Single-cell characteristics and malignancy regulation of alpha-fetoprotein-producing gastric cancer. Cancer Med. 2023;12(10):12018\u201333.","journal-title":"Cancer Med"},{"issue":"3","key":"6055_CR38","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/apm.13196","volume":"130","author":"J Lu","year":"2022","unstructured":"Lu J, Jin M, Zhou X, et al. Clinicopathological and molecular characteristics of the alpha-fetoprotein-producing gastric cancer: emphasis on two major subtypes. APMIS. 2022;130(3):169\u201380.","journal-title":"APMIS"},{"issue":"1B","key":"6055_CR39","first-page":"643","volume":"17","author":"K Kitamura","year":"1997","unstructured":"Kitamura K, Yamaguchi T, Okamoto K, et al. Clinicopathologic features of synchronous multifocal early gastric cancers. Anticancer Res. 1997;17(1B):643\u20136.","journal-title":"Anticancer Res"},{"issue":"6","key":"6055_CR40","doi-asserted-by":"publisher","first-page":"873","DOI":"10.3346\/jkms.2016.31.6.873","volume":"31","author":"JH Kim","year":"2016","unstructured":"Kim JH, Jeong SH, Yeo J, et al. Clinicopathologic similarities of the main and minor lesions of synchronous multiple early gastric cancer. J Korean Med Sci. 2016;31(6):873\u20138.","journal-title":"J Korean Med Sci"},{"issue":"2","key":"6055_CR41","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.gie.2011.04.009","volume":"74","author":"J Choi","year":"2011","unstructured":"Choi J, Kim SG, Im JP, et al. Lymph node metastasis in multiple synchronous early gastric cancer. Gastrointest Endosc. 2011;74(2):276\u201384.","journal-title":"Gastrointest Endosc"},{"issue":"3","key":"6055_CR42","doi-asserted-by":"publisher","first-page":"266","DOI":"10.5946\/ce.2017.109","volume":"51","author":"HJ Lee","year":"2018","unstructured":"Lee HJ, Lee YJ, Lee JY, et al. Characteristics of synchronous and metachronous multiple gastric tumors after endoscopic submucosal dissection of early gastric neoplasm. Clin Endosc. 2018;51(3):266\u201373.","journal-title":"Clin Endosc"},{"issue":"41","key":"6055_CR43","doi-asserted-by":"publisher","first-page":"7154","DOI":"10.3748\/wjg.v19.i41.7154","volume":"19","author":"T Isobe","year":"2013","unstructured":"Isobe T, Hashimoto K, Kizaki J. Characteristics and prognosis of synchronous multiple early gastric cancer. World J Gastroenterol. 2013;19(41):7154\u20139.","journal-title":"World J Gastroenterol"},{"issue":"5","key":"6055_CR44","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1007\/BF01655194","volume":"9","author":"Y Noguchi","year":"1985","unstructured":"Noguchi Y, Ohta H, Takagi K, et al. Synchronous multiple early gastric carcinoma: a study of 178 cases. World J Surg. 1985;9(5):786\u201393.","journal-title":"World J Surg"},{"issue":"2","key":"6055_CR45","doi-asserted-by":"publisher","first-page":"154","DOI":"10.5230\/jgc.2017.17.e19","volume":"17","author":"DH Kim","year":"2017","unstructured":"Kim DH, Kim SM, Choi MG, et al. Multiple primary malignancies in patients with multiple early gastric cancer. J Gastric Cancer. 2017;17(2):154\u201361.","journal-title":"J Gastric Cancer"},{"issue":"12","key":"6055_CR46","doi-asserted-by":"publisher","first-page":"5489","DOI":"10.7150\/thno.42814","volume":"10","author":"A Wang","year":"2020","unstructured":"Wang A, Li Z, Wang M, et al. Molecular characteristics of synchronous multiple gastric cancer. Theranostics. 2020;10(12):5489\u2013500.","journal-title":"Theranostics"},{"issue":"8","key":"6055_CR47","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1007\/s00535-019-01547-z","volume":"54","author":"S Takaoka","year":"2019","unstructured":"Takaoka S, Hirotsu Y, Ohyama H, et al. Molecular subtype switching in early-stage gastric cancers with multiple occurrences. J Gastroenterol. 2019;54(8):674\u201386.","journal-title":"J Gastroenterol"},{"issue":"2","key":"6055_CR48","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1002\/path.4932","volume":"243","author":"X Xing","year":"2017","unstructured":"Xing X, Jia S, Wu J, et al. Clonality analysis of synchronous gastro-oesophageal junction carcinoma and distal gastric cancer by whole-exome sequencing. J Pathol. 2017;243(2):165\u201375.","journal-title":"J Pathol"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-026-06055-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-026-06055-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-026-06055-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:02:00Z","timestamp":1780272120000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13256-026-06055-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,20]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6055"],"URL":"https:\/\/doi.org\/10.1186\/s13256-026-06055-2","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,20]]},"assertion":[{"value":"31 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Liaoning Cancer Hospital &Institute, and informed consent was obtained from all participants. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee(s) and with the Helsinki Declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consents were obtained from the patients for publication of this case report and any accompanying images. The copy of the written consents is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare that they have no any conflict of interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"299"}}